Do systemic inflammation and disrupted sleep create a self-perpetuating loop that dysregulates the HPA axis?

Research indicates that systemic inflammation and sleep disruption are not just symptoms of one another but are locked in a self-perpetuating bidirectional feedback loop. This interaction significantly impacts the Hypothalamic-Pituitary-Adrenal (HPA) axis, creating a complex cycle of physiological stress.

Clinical and effectiveness evidence

Extensive clinical data, including a meta-analysis of over 50,000 participants, demonstrates that sleep disturbance—whether from chronic insomnia, acute restriction, or fragmentation—robustly elevates systemic inflammatory markers such as C-reactive protein (CRP) and Interleukin-6 (IL-6).

• Sleep loss effects: Experimental studies show that even partial sleep restriction (4 hours per night for 4–5 nights) can increase CRP levels by 0.5–1.0 mg/L.
• Inflammation effects: Conversely, systemic inflammation causally degrades sleep. Clinical interventions using anti-inflammatory agents, such as anti-TNF-α therapy in rheumatoid arthritis patients, have shown significant improvements in sleep efficiency (rising from 73.9% to 85.4%) and reductions in wakefulness after sleep onset.

Mechanistic explanations

The feedback loop is mediated by shared neuro-immune signaling pathways:

• The Sleep-to-Inflammation Path: Sleep deprivation acts as a biological stressor that activates the sympathetic nervous system (SNS). This triggers the release of catecholamines that bind to $\beta$-adrenergic receptors on immune cells, activating the NF-$\kappa$B pathway—the "master switch" for pro-inflammatory cytokine production (IL-1$\beta$, IL-6, TNF-α).
• The Inflammation-to-Sleep Path: Pro-inflammatory cytokines act as "somnogenic" signaling molecules. At physiological levels, they regulate normal sleep; however, at the pathological levels seen in systemic inflammation, they penetrate or signal across the blood-brain barrier to disrupt hypothalamic sleep-wake centers (like the VLPO), leading to fragmented sleep and reduced slow-wave (deep) sleep.

HPA-axis disruption

The intersection of poor sleep and inflammation eventually dysregulates the HPA axis through several maladaptive mechanisms:

• Glucocorticoid Resistance: Chronic inflammation and sleep loss promote resistance in glucocorticoid receptors. This means immune cells become less responsive to cortisol's natural anti-inflammatory effects, allowing inflammation to persist even when cortisol is present.
• HPA "Burnout": While acute sleep loss initially spikes cortisol, chronic disruption can lead to a blunted cortisol awakening response (CAR) and an "adrenal shift." This shift favors cortisol production at the expense of adrenal androgens, resulting in low DHEA-S levels and an elevated cortisol-to-DHEA ratio, signaling a pro-catabolic state.

Bottom line

Systemic inflammation and sleep disruption reinforce each other through SNS activation and cytokine signaling, eventually causing HPA-axis dysregulation and glucocorticoid resistance. For patients, particularly females over 50, addressing both sleep hygiene and inflammatory drivers (such as metabolic health or chronic stress) is essential to breaking this cycle.